These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 15630389

  • 21. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE.
    Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
    [Abstract] [Full Text] [Related]

  • 22. The effect of sex hormones on bone metabolism of the otic capsule--an overview.
    Horner KC.
    Hear Res; 2009 Jun; 252(1-2):56-60. PubMed ID: 19121641
    [Abstract] [Full Text] [Related]

  • 23. Differential gene expression in the otic capsule and the middle ear--an annotation of bone-related signaling genes.
    Nielsen MC, Martin-Bertelsen T, Friis M, Winther O, Friis-Hansen L, Rye-Jørgensen N, Bloch S, Sørensen MS.
    Otol Neurotol; 2015 Apr; 36(4):727-32. PubMed ID: 25406873
    [Abstract] [Full Text] [Related]

  • 24. Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene.
    Bashir A, Mak YT, Sankaralingam S, Cheung J, McGowan NW, Grigoriadis AE, Fogelman I, Hampson G.
    Steroids; 2005 Dec 01; 70(13):847-55. PubMed ID: 16005483
    [Abstract] [Full Text] [Related]

  • 25. Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells.
    Maddi A, Hai H, Ong ST, Sharp L, Harris M, Meghji S.
    Bone; 2006 Aug 01; 39(2):283-8. PubMed ID: 16567138
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol.
    Ishizuka K, Hirukawa K, Nakamura H, Togari A.
    Neurosci Lett; 2005 Apr 29; 379(1):47-51. PubMed ID: 15814197
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
    Padagas J, Colloton M, Shalhoub V, Kostenuik P, Morony S, Munyakazi L, Guo M, Gianneschi D, Shatzen E, Geng Z, Tan HL, Dunstan C, Lacey D, Martin D.
    Calcif Tissue Int; 2006 Jan 29; 78(1):35-44. PubMed ID: 16362459
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
    Jeong JH, Park CW, Tae K, Lee SH, Shin DH, Kim KR, Park YW.
    Laryngoscope; 2006 Jul 29; 116(7):1180-4. PubMed ID: 16826057
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.
    Crisafulli A, Micari A, Altavilla D, Saporito F, Sardella A, Passaniti M, Raffa S, D'anneo G, Lucà F, Mioni C, Arrigo F, Squadrito F.
    Clin Sci (Lond); 2005 Oct 29; 109(4):389-95. PubMed ID: 15926884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.